Dipak Panigrahy
- Molecular Biology top 5%
- Cancer Research top 1%
- Oncology top 5%
- Biochemistry top 0.5%
- Pharmacology top 2%
- Co-authors
- Lynn HlatkyPhilip HahnfeldtSui HuangArja KaipainenMark W. KieranJudah FolkmanBruce D. HammockEmily R. Greene
- Topics
- Eicosanoids and Hypertension Pharmacology (15 papers)Cancer, Hypoxia, and Metabolism (12 papers)Peroxisome Proliferator-Activated Receptors (12 papers)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Dipak Panigrahy
44 papers receiving 4.4k citations
Hit Papers
Peers
Comparison fields: 5 of 139
- Molecular Biology 2.4k
- Cancer Research 1.4k
- Oncology 772
- Biochemistry 761
- Pharmacology 499
Countries citing papers authored by Dipak Panigrahy
This map shows the geographic impact of Dipak Panigrahy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dipak Panigrahy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dipak Panigrahy more than expected).
Fields of papers citing papers by Dipak Panigrahy
This network shows the impact of papers produced by Dipak Panigrahy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dipak Panigrahy. The network helps show where Dipak Panigrahy may publish in the future.
Co-authorship network of co-authors of Dipak Panigrahy
This figure shows the co-authorship network connecting the top 25 collaborators of Dipak Panigrahy. A scholar is included among the top collaborators of Dipak Panigrahy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dipak Panigrahy. Dipak Panigrahy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 12 | |
| 2 | 103 | |
| 3 | 2 | |
| 4 | 139 | |
| 5 | 111 | |
| 6 | 144 | |
| 7 | 29 | |
| 8 | 241 | |
| 9 | 19 | |
| 10 | 34 | |
| 11 | 142 | |
| 12 | 15 | |
| 13 | 8 | |
| 14 | 74 | |
| 15 | 118 | |
| 16 | 366 | |
| 17 | 240 | |
| 18 | 308 | |
| 19 | 21 | |
| 20 | 69 |
About Dipak Panigrahy
Dipak Panigrahy is a scholar working on Biochemistry, Cancer Research and Pharmacology, having authored 45 papers that have together received 4.5k indexed citations. Recurring topics across this work include Eicosanoids and Hypertension Pharmacology (15 papers), Cancer, Hypoxia, and Metabolism (12 papers) and Peroxisome Proliferator-Activated Receptors (12 papers). The work is most often cited by research in Biochemistry (761 citations), Cancer Research (1.4k citations) and Modeling and Simulation (320 citations). Dipak Panigrahy has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Lynn Hlatky, Philip Hahnfeldt, Sui Huang, Arja Kaipainen, Mark W. Kieran, Judah Folkman, Judah Folkman, Bruce D. Hammock, Emily R. Greene and Charles N. Serhan. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.